FOSTER CITY Calif Jan GLOBE NEWSWIRE -- Terns Pharmaceuticals Inc Terns or the Company Nasdaq TERN a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases including oncology obesity and non-alcoholic steatohepatitis NASH today announced that it has granted as of January an equity inducement award to a new employee under the terms of the...
Globe News Wire
SEATTLE Jan GLOBE NEWSWIRE -- Sana Biotechnology Inc NASDAQ SANA a company focused on changing the possible for patients through engineered cells today announced that it will webcast its presentation at the nd Annual J P Morgan Healthcare Conference at a m PT on Tuesday January The presentation will feature a business overview and update by Steve Harr Sana s...
Monthly information related to total number of voting rights and shares composing the share capital December Article - of general regulation of French Autorit des March s Financiers Listing markets Euronext Paris from Euronext Market segment C - ISIN Code FR K B - Symbol PHXM amp Nasdaq Global Select Market in the United-States Symbol PHXM Website www phaxiam com...
Dr Praveen Tipirneni returns in full capacity as Chief Executive Officer from medical leave- WALTHAM Mass Jan GLOBE NEWSWIRE -- Morphic Therapeutic Nasdaq MORF a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases today announced that Praveen Tipirneni M D Chief Executive Officer of Morphic has returned in full capacity from...